Announcement

Collapse
No announcement yet.

Vaccine . Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Vaccine . Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination

    Vaccine


    . 2024 Jul 8:S0264-410X(24)00757-6.
    doi: 10.1016/j.vaccine.2024.07.017. Online ahead of print. Reduced cell-mediated immune response in hyperglycemic NOD mice following influenza vaccination

    Ji Young Bang 1 , Yun Ji Kim 1 , Young-Jin Seo 2 , So-Hee Hong 3



    AffiliationsAbstract

    Due to the higher risk of medical complications posed by influenza infection, patients with type 1 diabetes (T1D) are strongly recommended to receive the influenza vaccine. However, it remains unclear if hyperglycemia in patients with T1D affects vaccine-induced immune responses. In this study, we investigated the humoral and cellular immune responses of prediabetic and diabetic, nonobese diabetic (NOD) mice following influenza vaccination to determine the effects of hyperglycemia on influenza vaccine-induced responses. In diabetic NOD mice, vaccine-specific IgG and IgM levels, as well as IgG-producing cells, were comparable to those in prediabetic NOD mice. However, the diabetic NOD mice exhibited reduced percentages of memory T cells and activated T cells in the spleen, along with reduced number of vaccine-specific interferon (IFN)-γ-secreting cells. Thus, these findings suggest that in patients with T1D, hyperglycemia could lead to impaired cell-mediated immune responses following influenza vaccination.

    Keywords: Cell-mediated immune response; Hyperglycemia; Influenza vaccine; Nonobese diabetic mice; Type 1 diabetes.

Working...
X